JCO Pulse - Effects of Sacubitril/Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy - SARAH Trial

Bonnie Ky, MD, and Marcely Gimenes Bonatto, MD, discuss the study design, findings, future research questions and the potential clinical impact of the use of sacubitril/valsartan for the prevention of cardiotoxicity in high-risk patients undergoing anthracycline chemotherapy.